Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
14
×
Tags
biotech
14
×
clinical trials
14
×
deals
14
×
life sciences
national blog main
san francisco blog main
san francisco top stories
14
×
boston blog main
national top stories
boston top stories
fda
investing
new york blog main
new york top stories
startups
boulder/denver blog main
boulder/denver top stories
cancer
indiana blog main
indiana top stories
national
wisconsin blog main
wisconsin top stories
detroit blog main
detroit top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
cancer immunotherapy
eli lilly
roche
takeda pharmaceutical
bristol-myers squibb
generic drugs
johnson & johnson
What
roundup
bio
companies
drug
cancer
days
ipo
medicines
biotech
fda
ahead
approval
asco
cash
deal
digital
drugs
growing
hasn’t
help
led
life
nash
new
news
raised
research
rnai
science
street
wall
week
welcomed
abandoning
acquisitions
ago
alliance
ambien
american
analytics
Language
unset
Current search:
biotech
×
deals
×
" clinical trials "
×
photo
×
" san francisco top stories "
×
@xconomy.com
3 years ago
Bio Roundup: CRISPR Kudos, Bristol Myers’s Buy, RNAi Alliance & More
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
PanTheryx Lands $50M to Use “First Milk” to Target Gut Microbiome
@xconomy.com
5 years ago
Bio Roundup: Generic Drugs Graft, ASCO Ahead, ElevateBio Rises & More
@xconomy.com
5 years ago
Bio Roundup: Biogen’s Strategy, Drug Price Convo, NASH News & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: #JPM19 Notes, Loxo Buyout, Black Diamond’s Cash & More
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
6 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More